Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $17.33 USD
Change Today 0.00 / 0.00%
Volume 0.0
SMGKF On Other Exchanges
Symbol
Exchange
OTC US
Berlin
London
As of 8:10 PM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

smiths group plc (SMGKF) Snapshot

Open
$17.69
Previous Close
$17.33
Day High
$17.69
Day Low
$17.33
52 Week High
05/13/14 - $22.97
52 Week Low
01/7/15 - $15.71
Market Cap
6.8B
Average Volume 10 Days
742.0
EPS TTM
--
Shares Outstanding
394.8M
EX-Date
03/26/15
P/E TM
--
Dividend
$46.58
Dividend Yield
4.06%
Current Stock Chart for SMITHS GROUP PLC (SMGKF)

Related News

No related news articles were found.

smiths group plc (SMGKF) Related Businessweek News

No Related Businessweek News Found

smiths group plc (SMGKF) Details

Smiths Group plc develops, manufactures, sells, and supports products and services for the threat and contraband detection, medical devices, energy, communications, and engineered components markets worldwide. The company's John Crane division offers engineered products comprising mechanical seals, seal support systems, engineered bearings, power transmission couplings, and specialist filtration systems for production, transmission and storage, refining, power generation, and petrochemical, as well as pump and compressor manufacturers. Its Smiths Medical division provides medication delivery systems to treat patients with acute and chronic disease and relieve pain; vital care products to reduce hospital-acquired infections, manage patients’ airways, maintain body temperature, and assist reproduction; and safety devices to prevent needlestick injuries and reduce cross-infection to hospitals; homecare, clinics, and other surgery centers; and original equipment manufacturers. The company's Smiths Detection division offers detection technologies, including X-ray, trace detection, and infra-red spectroscopy that detect and identify explosives, weapons, chemical agents, biohazards, nuclear and radioactive material, narcotics, and contraband. Its Smiths Interconnect division provides electronic and radio frequency components and sub-systems that connect, protect, and control critical systems for data centre, wireless telecommunications, aerospace, defense, space, medical, rail, test, and industrial markets. The company's Flex-Tek offers engineered components comprising hosing and rigid tubing, heating elements, and thermal systems that heat and move fluids and gases for the aerospace, medical, industrial, construction, and domestic appliance markets. The company was formerly known as Smiths Industries and changed its name to Smiths Group plc in 2000. Smiths Group plc was founded in 1851 and is headquartered in London, the United Kingdom.

24,100 Employees
Last Reported Date: 09/16/14
Founded in 1851

smiths group plc (SMGKF) Top Compensated Officers

Chief Executive Officer and Executive Directo...
Total Annual Compensation: 1.5M GBP
Compensation as of Fiscal Year 2014.

smiths group plc (SMGKF) Key Developments

Smiths Group plc Announces Executive Changes

Smiths Group plc announced the appointment of Chris O'Shea as its new Finance Director, effective from 18 September 2015. Chris, is currently Chief Financial Officer of the FTSE-250 company Vesuvius plc, a global leader in molten metal flow engineering. He formerly held senior international finance posts in BG Group plc and Royal Dutch Shell plc. As previously announced, Rob White will continue as Interim Chief Financial Officer until Chris takes up his new post. Rob White, who replaced Peter Turner when he stepped down as Finance Director, will return to his position as Vice President, Global Finance for Smiths Medical following his temporary assignment.

Smiths Group plc Announces Management Changes

Smiths Group plc announced the appointment of Rob White as Interim Chief Financial Officer with effect from 25 April 2015, assuming that no permanent successor has been appointed in the meantime. He will replace Peter Turner until a permanent replacement is in post. Rob White has been Vice President, Global Finance for Smiths Medical for the last six years and will return to this role following this interim assignment. He will join the Executive Committee of Smiths Group and attend Board meetings but will not be appointed an Executive Director of the Board. As announced in October last year, Peter Turner will step down as Finance Director on 24 April 2015 to pursue opportunities outside the Group.

Smiths Group plc Declares Interim Dividend, Payable on April 24, 2015; Reports Unaudited Consolidated Earnings Results for the Six Months Ended January 31, 2015

The Board of Smiths Group plc has declared an interim dividend of 13.00 pence per share, an increase of 2% reflecting the strong cash conversion in the period. The interim dividend will be paid on 24 April 2015 to shareholders registered at the close of business on 27 March 2015. The ex-dividend date is 26 March 2015. The company reported unaudited consolidated earnings results for the six months ended January 31, 2015. For the period, the company reported revenue of £1,416 million against £1,442 million a year ago. Operating profit was £164 million against £170 million a year ago. Profit before taxation was £131 million against £132 million a year ago. Profit for the period attributable to the company’s share holders was £86 million against £94 million a year ago. Earnings per diluted share were 21.6 pence against 23.6 pence a year ago. Net cash inflow from operating activities was £112 million against £83 million a year ago. Expenditure on other intangible assets was £8.0 million against £8.0 million a year ago. Expenditure on capitalized development was £8 million against £13.0 million a year ago. Purchases of property, plant and equipment was £28 million against £24 million a year ago. Headline operating profit was £245 million against £504 million a year ago. Headline profit before taxation was £208 million against £215 million a year ago. Headline profit after taxation - continuing operations was £153 million against £157 million a year ago. Headline EBITDA was £272 million against £285.0 million a year ago. Headline diluted EPS was 38.2 pence against 39.2 pence a year ago. Net debt as at January 31, 2015 was £929 million against £901 million debt as at January 31, 2014. Headline operating cash-flow was £204 million against £211 million a year ago. Free cash-flow was £58 million against £30 million a year ago. Return on capital employed was 15.4% against 16.6% a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SMGKF:US $17.33 USD 0.00

SMGKF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Babcock International Group PLC 1,002 GBp -7.00
Exelis Inc $24.62 USD +0.10
Flowserve Corp $56.65 USD -1.88
Meggitt PLC 529.50 GBp -0.50
Weir Group PLC/The 1,885 GBp +5.00
View Industry Companies
 

Industry Analysis

SMGKF

Industry Average

Valuation SMGKF Industry Range
Price/Earnings 20.3x
Price/Sales 1.5x
Price/Book 3.7x
Price/Cash Flow 20.0x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SMITHS GROUP PLC, please visit www.smiths.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.